commencement of sales..., page-2

As I said, I really can't understand the logic of anyone selling under 2c given:-

- it is tax time, so there is always loose stock
- directors contributed $1M+ at 2c
- we have 4c options to get in the money by September

I expect a regular flow of news now, given it is the new financial year, they have sorted their supply issues and have every incentive to get the stock to around 5c to get the additional $4M in from the ALTO's.

Great announcement IMO. Would be interested to know how much the MediFlush costs, as if it saves around $2.50 per nurse medication event and it costs the hospital around the same, it should be a company maker.

It is now all about exposure. If the product is as great as the hospitals are saying and is actually saves them more than it costs, wide scale adoption would be expected. It is just a matter of getting the product into a few majors and waiting for the domino effect